Semaglutide Investigated for Reducing Liver Scarring and Fat in Early-Stage NAFLD Patients
A Study on How Semaglutide Works on Early Stages of Scar Tissue in the Liver Assessed by Pictures of the Liver
Abstract
A randomized, placebo-controlled clinical trial is evaluating semaglutide's effect on early liver fibrosis and fat deposition in patients with nonalcoholic fatty liver disease.